CAS 1470018-52-0

AMG2850

CAS : 1470018-52-0

AMG2850

Degré de pureté : ≥98%

Masse moléculaire : 417.35g/mol

Ref: 54-BUP07043

AMG 2850

CAS : 1470018-52-0

AMG 2850 is an investigational monoclonal antibody, which is derived from recombinant DNA technology with a specific mode of action targeting cancer cells. This therapeutic agent functions by binding to specific antigens expressed on the surface of malignant cells, thereby activating immune-mediated cytotoxic mechanisms or blocking signaling pathways crucial for tumor growth and survival. The precision of this antibody in targeting cancer cell antigens minimizes its impact on healthy cells, reducing potential side effects typically associated with broader-spectrum chemotherapies.

Formule : C₁₉H₁₇F₆N₃O

Degré de pureté : Min. 95%

Masse moléculaire : 417.3 g/mol

Ref: 3D-VIC01852

AMG2850

CAS : 1470018-52-0

AMG2850 is a potent, orally bioavailable, and selective antagonist of transient receptor potential melastatin 8 (TRPM8).

Formule : C₁₉H₁₇F₆N₃O

Degré de pureté : 99.84%

Couleur et forme : Solid

Masse moléculaire : 417.35

Ref: TM-T10300